← FDA Drug Approvals (Drugs@FDA)

RIVAROXABAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AIPING PHARM INC · Approved 2025-05-14

Drug application

FDA Application #

ANDA216995

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIVAROXABAN

Generic name

RIVAROXABAN

Active ingredients

RIVAROXABAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AIPING PHARM INC

Manufacturer

Changzhou Pharmaceutical Factory

First approval

2025-05-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown